Search International and National Patent Collections
|1. (WO2017031993) CORRELATION BETWEEN LONG NON-CODING RNA H19 AND CANCER PLATINUM-BASED CHEMOTHERAPEUTIC DRUG RESISTANCE|
|Title:||CORRELATION BETWEEN LONG NON-CODING RNA H19 AND CANCER PLATINUM-BASED CHEMOTHERAPEUTIC DRUG RESISTANCE|
Provided are uses of an agent capable of reducing and/or inhibiting the expression of long non-coding RNA H19 in cancer cells in the preparation of a medicine for treating or preventing cancers, and in the preparation of a medicine for reducing the resistance of cancers to the platinum-based chemotherapeutic drug. Also provided is a use of an agent capable of detecting the expression of a long non-coding RNA H19 in the preparation of a test kit, the test kit being used for diagnosing the occurrence of cancers or predicting a cancer relapse, and for predicting, detecting or diagnosing the resistance to the platinum-based chemotherapeutic drug of a cancer patient.